Drug
Eos 448
Eos 448: highest development phase Phase 1/2, developed by iTeos Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- iTeos Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EOS-448 NCT05060432 | Phase 1/2 | Advanced Cancer |
Latest
No recent events.
Follow Eos 448 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.